AGP Picks
View all

Wellness Today St. Kitts & Nevis
Provided by AGP

Wellness Today St. Kitts & Nevis: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Today St. Kitts & Nevis.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 25, 2026

Papa Joins CMS GUIDE Model to Transform Dementia Care at Home
Jun. 25, 2026

Papa Joins CMS GUIDE Model to Transform Dementia Care at Home

Indeterminate GlobeNewswire
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
Jun. 25, 2026

Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes

Indeterminate GlobeNewswire
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Jun. 25, 2026

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
Jun. 25, 2026

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

Indeterminate GlobeNewswire
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
Jun. 25, 2026

Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program

Indeterminate GlobeNewswire
NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease
Jun. 25, 2026

NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease

Indeterminate GlobeNewswire
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
Jun. 25, 2026

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform

Indeterminate GlobeNewswire
MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer
Jun. 25, 2026

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Jun. 25, 2026

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

Indeterminate GlobeNewswire
Atalan Launches Nurse Retention Platform Designed to Identify Risk Up to 12 Months in Advance
Jun. 25, 2026

Atalan Launches Nurse Retention Platform Designed to Identify Risk Up to 12 Months in Advance

Indeterminate GlobeNewswire
Lab52 n-HAP Kids Toothpaste Named “Toothpaste Product of the Year” In 2026 Baby Innovation Awards
Jun. 25, 2026

Lab52 n-HAP Kids Toothpaste Named “Toothpaste Product of the Year” In 2026 Baby Innovation Awards

Indeterminate GlobeNewswire
Data Presented on Two-Year Proximal Neck Dynamics from First-in-Human Study of Abdominal Aortic Aneurysm Treatment
Jun. 25, 2026

Data Presented on Two-Year Proximal Neck Dynamics from First-in-Human Study of Abdominal Aortic Aneurysm Treatment

Indeterminate GlobeNewswire
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
Jun. 25, 2026

Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)

Indeterminate GlobeNewswire
Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
Jun. 25, 2026

Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial

Indeterminate GlobeNewswire
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun. 25, 2026

Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Indeterminate GlobeNewswire
TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth
Jun. 25, 2026

TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth

Indeterminate GlobeNewswire
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
Jun. 25, 2026

Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
Jun. 25, 2026

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Indeterminate GlobeNewswire
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
Jun. 25, 2026

Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel

Indeterminate GlobeNewswire
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Jun. 25, 2026

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Wellness Today St. Kitts & Nevis

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.